Home Authors Posts by Carmen Lehman

Carmen Lehman

73 POSTS 0 COMMENTS
Carmen Lehman is a senior writer for Seneca Globe News and covers biotechnology, drugs, basic materials and technology. For more information email Lehman, carmen.lehman@senecaglobe.com
bioAffinity Technologies
Biotech-Pharma

bioAffinity Technologies, Inc. (NASDAQ:BIAF) Public Offering Increases to Around $15.6M

Carmen Lehman -
0
Acumen Pharmaceuticals Inc
Biotech-Pharma

Acumen Pharmaceuticals Inc (NASDAQ:ABOS) Soars on Strong Findings of Phase 3 Alzhemier’s Study

Carmen Lehman -
0
amd ryzen 7020
AMD

Advanced Micro Devices, Inc. (NASDAQ:AMD) Overstretching to Expand Through Ryzen & Athlon Processor

Carmen Lehman -
0
AstraZeneca Evusheld
Biotech-Pharma

AstraZeneca plc’s (NASDAQ: AZN) Evusheld Permitted by Japanese Authority For COVID-19 Treatment

Carmen Lehman -
0
1...16171819Page 17 of 19
© Newspaper WordPress Theme by TagDiv